Prion disease: clinical pathway development for the terminally ill
BMJ Support Palliat Care
.
2022 Oct 14:spcare-2022-003877.
doi: 10.1136/spcare-2022-003877.
Online ahead of print.
Authors
Roseanagh Hogg
1
2
,
John Centola
3
,
Kirsty Durley
4
,
Chloe Antoinette Chin
5
,
Rachel Quibell
6
,
Helena Spriggs
7
,
Matthew Carey
2
8
,
Tomasz Bajorek
9
,
Mary Miller
2
,
Victoria Bradley
2
,
Suvankar Pal
3
Affiliations
1
Palliative Medicine, Health Education Thames Valley - HETV, Oxford, UK r.hogg1@nhs.net.
2
Palliative Medicine, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
3
Neurology, National CJD Research and Surveillance Unit, Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK.
4
Palliative Medicine, Health Education Thames Valley - HETV, Oxford, UK.
5
Palliative Medicine, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
6
Palliative Medicine, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, UK.
7
Health Education North East, Newcastle upon Tyne, England, UK.
8
Palliative Medicine, Sir Michael Sobell House Hospice, Oxford, UK.
9
Psychological Medicine, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
PMID:
36241387
DOI:
10.1136/spcare-2022-003877
No abstract available
Keywords:
Neurological conditions; Service evaluation; Symptoms and symptom management.
Publication types
Letter